205 related articles for article (PubMed ID: 30558624)
21. Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer.
Ren N; Tian Z; Sun H; Lu X
Med Sci Monit; 2020 Aug; 26():e924590. PubMed ID: 32827429
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA H19 may be a marker for prediction of prognosis in the follow-up of patients with papillary thyroid cancer.
Jiao X; Lu J; Huang Y; Zhang J; Zhang H; Zhang K
Cancer Biomark; 2019; 26(2):203-207. PubMed ID: 31403942
[TBL] [Abstract][Full Text] [Related]
23. The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
Kim K; Kim JH; Park IS; Rho YS; Kwon GH; Lee DJ
World J Surg; 2018 Nov; 42(11):3624-3631. PubMed ID: 29750323
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.
Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma.
Che X; Zhang G; Zhang X; Xue J
Med Sci Monit; 2018 May; 24():3540-3548. PubMed ID: 29805156
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
[TBL] [Abstract][Full Text] [Related]
27. Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
Brennan K; Holsinger C; Dosiou C; Sunwoo JB; Akatsu H; Haile R; Gevaert O
BMC Cancer; 2016 Sep; 16(1):736. PubMed ID: 27633254
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer.
Suh HY; Choi H; Paeng JC; Cheon GJ; Chung JK; Kang KW
BMC Cancer; 2019 Dec; 19(1):1260. PubMed ID: 31888560
[TBL] [Abstract][Full Text] [Related]
29. The prognostic potential of alpha-1 type I collagen expression in papillary thyroid cancer.
Huang C; Yang X; Han L; Fan Z; Liu B; Zhang C; Lu T
Biochem Biophys Res Commun; 2019 Jul; 515(1):125-132. PubMed ID: 31128912
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
31. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
Gu Y; Feng C; Liu T; Zhang B; Yang L
PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
[TBL] [Abstract][Full Text] [Related]
32. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Signature Comprising 5 Soluble Carrier Family Genes to Predict the Recurrence of Papillary Thyroid Carcinoma.
Han R; Sun W; Zhang H
Technol Cancer Res Treat; 2021; 20():15330338211036314. PubMed ID: 34590520
[TBL] [Abstract][Full Text] [Related]
35. The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia.
Lai B; Lai Y; Zhang Y; Zhou M; Sheng L; OuYang G
Technol Cancer Res Treat; 2020; 19():1533033819894308. PubMed ID: 31918632
[TBL] [Abstract][Full Text] [Related]
36. High Expression of Yes-activated Protein-1 in Papillary Thyroid Carcinoma Correlates With Poor Prognosis.
Liu Z; Zeng W; Maimaiti Y; Ming J; Guo Y; Liu Y; Liu C; Huang T
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):59-64. PubMed ID: 28682834
[TBL] [Abstract][Full Text] [Related]
37. Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
Ito Y; Miyauchi A; Oda H; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2019 Feb; 66(2):127-134. PubMed ID: 30626761
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Tiam1 expression in papillary thyroid carcinoma.
Hsueh C; Lin JD; Yang CF; Chang YS; Chao TC; Sun JH; Wu IC; Tseng NM; Ueng SH
Virchows Arch; 2011 Dec; 459(6):587-93. PubMed ID: 22075848
[TBL] [Abstract][Full Text] [Related]
39. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
Zhai T; Muhanhali D; Jia X; Wu Z; Cai Z; Ling Y
Endocrine; 2019 Dec; 66(3):573-584. PubMed ID: 31332712
[TBL] [Abstract][Full Text] [Related]
40. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
